Guan X, Xiang W, Qu K, Ahmed Z, Liu J, Cai M
BMC Genomics. 2025; 26(1):216.
PMID: 40038604
PMC: 11881512.
DOI: 10.1186/s12864-024-11033-3.
Stebbing J, Bullock A
J Immunother Cancer. 2025; 13(2).
PMID: 40010768
PMC: 11865770.
DOI: 10.1136/jitc-2024-011142.
Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G
Mol Cancer. 2025; 24(1):52.
PMID: 39994696
PMC: 11852583.
DOI: 10.1186/s12943-025-02265-2.
Yang Q, Xiao J, Lan Y
Front Oncol. 2025; 15:1563949.
PMID: 39990681
PMC: 11842240.
DOI: 10.3389/fonc.2025.1563949.
Miller W, Mishra A, Sheedy C, Bond A, Gardner B, Montell D
bioRxiv. 2025; .
PMID: 39990418
PMC: 11844498.
DOI: 10.1101/2025.02.11.637707.
Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties.
Jeppesen D, Sanchez Z, Kelley N, Hayes J, Ambroise J, Koory E
Nat Cell Biol. 2025; 27(3):438-448.
PMID: 39984653
PMC: 11906356.
DOI: 10.1038/s41556-025-01621-0.
Target cell adhesion limits macrophage phagocytosis and promotes trogocytosis.
Rollins K, Fiaz S, Morrissey M
bioRxiv. 2025; .
PMID: 39975079
PMC: 11839035.
DOI: 10.1101/2025.02.06.636906.
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies.
Ebinama U, George B
Discov Oncol. 2025; 16(1):89.
PMID: 39864030
PMC: 11769894.
DOI: 10.1007/s12672-025-01797-9.
Advancements and Challenges in Immune Protection Strategies for Islet Transplantation.
Wang X, Zeng Z, Li D, Wang K, Zhang W, Yu Y
J Diabetes. 2025; 17(1):e70048.
PMID: 39829227
PMC: 11744047.
DOI: 10.1111/1753-0407.70048.
Macrophage-based pathogenesis and theranostics of vulnerable plaques.
Fang F, Wang E, Fang M, Yue H, Yang H, Liu X
Theranostics. 2025; 15(4):1570-1588.
PMID: 39816684
PMC: 11729549.
DOI: 10.7150/thno.105256.
Investigation of CD47 Expression in Renal Cell Tumors and Evaluation of Its Relationship with Prognostic Parameters.
Dizibuyuk O, Bozdag Z, Karakok M
Diagnostics (Basel). 2025; 15(1.
PMID: 39795582
PMC: 11719943.
DOI: 10.3390/diagnostics15010053.
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implications.
Li X, Han H, Yang K, Li S, Ma L, Yang Z
Front Immunol. 2025; 15():1476427.
PMID: 39776907
PMC: 11703838.
DOI: 10.3389/fimmu.2024.1476427.
Phosphoproteomic Profiling Reveals mTOR Signaling in Sustaining Macrophage Phagocytosis of Cancer Cells.
Wang B, Cao X, Garcia-Mansfield K, Zhou J, Manousopoulou A, Pirrotte P
Cancers (Basel). 2025; 16(24.
PMID: 39766137
PMC: 11674635.
DOI: 10.3390/cancers16244238.
Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite.
Bond A, Morrissey M
J Cell Sci. 2025; 138(1).
PMID: 39749603
PMC: 11828473.
DOI: 10.1242/jcs.263513.
NRF-1 transcription factor regulates expression of an innate immunity checkpoint, CD47, during melanomagenesis.
Makwana K, Velazquez E, Marzese D, Smith B, Bhowmick N, Faries M
Front Immunol. 2025; 15:1495032.
PMID: 39742254
PMC: 11685207.
DOI: 10.3389/fimmu.2024.1495032.
Characterisation and hierarchy of the spermatogonial stem cell compartment in human spermatogenesis by spectral cytometry using a 16-colors panel.
Lapoujade C, Blanco M, Givelet M, Gille A, Allemand I, Lenez L
Cell Mol Life Sci. 2024; 82(1):15.
PMID: 39725808
PMC: 11671462.
DOI: 10.1007/s00018-024-05496-6.
Biogenesis and functional implications of extracellular vesicles in cancer metastasis.
Sekar S, Srikanth S, Mukherjee A, Gopalakrishnan A, Wanjari U, Vellingiri B
Clin Transl Oncol. 2024; .
PMID: 39704958
DOI: 10.1007/s12094-024-03815-8.
AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane.
Pan Y, Yin Q, Wang Z, Wu G, Liu K, Li X
Transl Oncol. 2024; 52():102240.
PMID: 39667226
PMC: 11699289.
DOI: 10.1016/j.tranon.2024.102240.
Ubiquitination of CD47 Regulates Innate Anti-Tumor Immune Response.
Gou Q, Yan B, Duan Y, Guo Y, Qian J, Shi J
Adv Sci (Weinh). 2024; 12(5):e2412205.
PMID: 39665172
PMC: 11792004.
DOI: 10.1002/advs.202412205.
Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential.
Yan G, Zhao S, Chen M, Mo S, Huang H, Liao Y
Front Pharmacol. 2024; 15:1469825.
PMID: 39664519
PMC: 11631591.
DOI: 10.3389/fphar.2024.1469825.